SCHEMBL12021945

SCHEMBL12021945

CCc1nc(-c2ccc(F)c(S)c2)no1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 2/20 0.48
▸ ACACA Q13085 2/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ MAPK1 P28482 2/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ S1PR3 Q99500 1/20 0.41
▸ NOTUM Q6P988 2/20 0.41
▸ MAPT P10636 4/20 0.41
▸ LMNA P02545 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPY2R P49146 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8415707 0.84 FFAR1 (0.53) ACACBACACANPC1RAB9ASMN1; SMN2
SCHEMBL8282776 0.82 ACACB (0.48) ACACBACACANPC1RAB9ASMN1; SMN2
SCHEMBL12021892 0.80 L3MBTL1 (0.57) NPC1RAB9ASMN1; SMN2HTTLMNA
SCHEMBL8226480 0.80 ACACB (0.46) ACACBACACANPC1RAB9ASMN1; SMN2
SCHEMBL26232436 0.78 NPC1 (0.73) ACACBACACANPC1RAB9ASMN1; SMN2
SCHEMBL24092055 0.76 TP53 (0.52) ACACBACACANPC1RAB9ASMN1; SMN2
SCHEMBL16202099 0.75 S1PR1 (0.55) ACACBACACANPC1RAB9ASMN1; SMN2
SCHEMBL201607 0.74 NOTUM (0.70) ACACBACACANPC1RAB9ASMN1; SMN2
SCHEMBL12021977 0.74 HDAC4 (0.43) —
SCHEMBL14873222 0.73 ACACB (0.57) ACACBACACANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934227-B1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORP (US) 2011-12-21 — — EP disclosed
Send feedback